You are here

Coronavirus Outbreak

Coronavirus Task Force

AdvaMed is actively working with key U.S. government agencies – including HHS, FDA, and CDC – as well government agencies around the world, to identify how the industry can help ensure that providers and patients everywhere have access to the medical technologies they need to help diagnose and fight this deadly virus.

As we continue to assess and respond to a crisis that continues to evolve, AdvaMed’s objective is to pool and disseminate industry knowledge, and share developments among our membership.

To that end, AdvaMed has assembled a coronavirus task force. Any AdvaMed member company is eligible to join. This task force meets during scheduled conference calls and provides readouts on the latest intel we are receiving from AdvaMed members, government agencies and other stakeholders.

Join the Task Force

AdvaMed Members Fight Coronavirus

Since the onset of the coronavirus (COVID-19) outbreak, AdvaMed member companies have donated millions of dollars’ worth of medical products and cash to hospitals, foundations and charities around the world. Medical device companies are responding to increased demand by ramping up production wherever possible, coordinating closely with governments to ensure the delivery of supplies where they are most needed, and in some cases, creating new devices and diagnostic tests to help effectively diagnose and treat sick patients.

We have assembled a collection of some of the efforts undertaken by AdvaMed member companies based on public statements.

Read more

In Vitro Diagnostic COVID-19 Test

In vitro diagnostic (IVD) manufacturers have taken key steps to increase patient access to coronavirus diagnostic testing in laboratories, hospitals, and other testing sites across the country to guide patient care and protect public health.

We have compiled a list of companies that have developed IVDs that have received Emergency Use Authorization from the U.S. Food and Drug Administration.

View the list